DIE VERWENDUNG VON NK-1 REZEPTOR ANTAGONISTEN FÜR DIE BEHANDLUNGEN VON STRESS STÖRUNGEN

摘要

The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of stress disorders without concomitant therapy with other anti-stress agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it.